Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
A straightforward rationale for incorporating Equal Weighted Indices into a portfolio, emphasizing diversification and simplicity.
22,501 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Ethereum isn't resting on its laurels. A bold plan for 2029 aims to streamline the network, cut costs, and attract bu...
Investors face a stark choice in 2026: back an infrastructure-focused sand and logistics player in the Permian or bac...
Travel demand is shifting, and investors are watching choice hotels (chh) 2025 with keen interest. This article break...
As TJX prepares for the (tjx) 2026 earnings call, investors should focus on sales trends, inventory discipline, and o...
Bitcoin slides toward $60,000 raise fresh concerns for BLOK, the blockchain-focused ETF. This report explains potenti...
ExxonMobil stock near $150 highlights a broader earnings and cash-flow story that many retail investors overlook. Her...
Oil prices sprint higher, then pull back, leaving investors on edge. This piece explains how those moves could push i...
Palantir has a large revenue backlog, a major Army contract on the books, and ambitious growth guidance. This analysi...
As markets remain unsettled in early 2026, retirees seek steady monthly income. A new briefing spotlights five safe, ...
Ibotta's Q1 2026 earnings reveal a company balancing rapid user growth with a longer road to sustainable profitabilit...
Broadcom has surged after April began, but the big question remains: is the rally sustainable? This guide breaks down...